Background
Mme [N], a self-employed speech therapist participating in France’s national health-insurance system, was informed by the regional health agency in November 2021 that she had been prohibited from practicing since September 15, 2021. She had not produced proof of COVID-19 vaccination, recovery, or a recognized medical contraindication as required by the Law of August 5, 2021 on management of the public-health crisis.
She brought expedited proceedings against the Isère primary health-insurance fund, seeking suspension of the vaccination requirement and orders preventing the fund from withholding reimbursement for her services or beginning proceedings to remove her from the insurance convention. The Grenoble Court of Appeal found no basis for interim relief because no manifestly unlawful disturbance had been established.
On appeal to the Court of Cassation, the practitioner argued that the lower court should have examined whether the requirement disproportionately infringed informed consent, physical integrity, freedom to conduct a business, and protections against discrimination based on sex and health status.
The Court’s Holding
The Court of Cassation dismissed the appeal. It held that the vaccination requirement pursued the legitimate objectives of protecting vulnerable patients, healthcare professionals, and public health. In the context of the epidemic’s rapid progression, emerging variants, and incomplete vaccination coverage among some healthcare professionals, the measure was not manifestly inappropriate. The resulting suspension from practice was temporary and ended upon compliance or legislative suspension of the requirement, making it proportionate to those objectives.
The Court also rejected the discrimination claims. Any indirect differential impact on women from vaccine side effects was objectively justified by the public-health objective and was not manifestly inappropriate in light of the established effectiveness of vaccination and the generally minor and temporary nature of adverse effects, except in very rare cases. Treating healthcare professionals differently from other workers was likewise justified by their duties toward patients and their particular exposure to infection. The restriction on freedom to conduct a business was strictly proportionate.
Several other legal provisions invoked by the practitioner were inapplicable or not directly enforceable. The EU Charter did not apply because the dispute did not involve implementation of EU law, and COVID-19 vaccines authorized conditionally for marketing were not medical experiments or clinical trials. Substituting these legal grounds for the appellate court’s reasoning, the Court held that the vaccination requirement did not disproportionately infringe consent, physical integrity, nondiscrimination protections, or economic freedom and therefore created no manifestly unlawful disturbance warranting interim relief.
Key Takeaways
- France’s COVID-19 vaccination requirement for covered healthcare professionals was a proportionate measure serving legitimate public-health and patient-protection objectives.
- A temporary prohibition on practice for noncompliance did not create a manifestly unlawful disturbance justifying emergency judicial relief.
- Alleged differential effects on women and different treatment of healthcare professionals did not establish unlawful discrimination because the distinctions were objectively justified and proportionate.
Why It Matters
The decision confirms that French courts may uphold mandatory vaccination rules affecting healthcare professionals when the rules are grounded in legislation, respond to a pressing public-health need, and impose temporary, proportionate professional consequences rather than forced medical treatment.
It also clarifies the limits of rights-based challenges in expedited proceedings: EU Charter provisions require a connection to the implementation of EU law, broadly framed international commitments may lack direct effect, and conditionally authorized vaccines are not thereby classified as experimental treatments or clinical trials.